Plataforma en Red
Banco Nacional de ADN Carlos III
Facebook Twitter YouTube
English Castellano
Banco Nacional de ADN Banco Nacional de ADN Banco Nacional de ADN Banco Nacional de ADN Banco Nacional de ADN Banco Nacional de ADN
Inicio » Publicaciones
Publicaciones relacionadas con el BNADN
LÓPEZ-MEJÍAS R, REMUZGO-MARTÍNEZ S, GENRE F, et al. Influence of MUC5B gene on antisynthetase syndrome. Sci Rep. 2020 Jan 29;10(1):1415. doi: 10.1038/s41598-020-58400-0
LÓPEZ-MEJÍAS R, GENRE F, REMUZGO-MARTÍNEZ S, et al. Influence of IL17A gene on the pathogenesis of immunoglobulin-A vasculitis. Clin Exp Rheumatol. 2020 Mar-Apr;38 Suppl 124(2):166-170. Epub 2020 Mar 25.
TORRES RJ. Toll-Like receptor 4 (TLR4) polymorphism rs2149356 and risk of gout in a Spanish cohort. Nucleosides Nucleotides Nucleic Acids. 2020 Jun 18:1-8. doi: 10.1080/15257770.2020.1780438.
FERNÁNDEZ-PUENTE E, SÁNCHEZ-MARTÍN MA, DE ANDRÉS J, et al. Expression and functional analysis of the hydrogen peroxide biosensors HyPer and HyPer2 in C2C12 myoblasts/myotubes and single skeletal muscle fibres. Sci Rep. 2020 Jan 21;10(1):871. doi: 10.1038/s41598-020-57821-1
SERRA-JUHÉ C, MARTOS-MORENO GA, BOU DE PIERI F, et al. Heterozygous rare genetic variants in non-syndromic early-onset obesity. Int J Obes (Lond) 2020; 44(4): 830–841.
GALLEGO-FABREGA C., CULLELL N., SORIANO-TÁRRAGA C., et al. DNA methylation of MMPs and TIMPs in atherothrombosis process in carotid plaques and blood tissues. Oncotarget. 2020; 11: 905-912.
GOMES C, QUINTERO-BRITO JD, MARTÍNEZ-GÓMEZ J, et al. Spanish allele and haplotype database for 32 X-chromosome Insertion-Deletion polymorphisms. Forensic Sci Int Genet. 2020 Feb 13;46:102262. doi: 10.1016/j.fsigen.2020.102262.
GONZÁLEZ-SERNA D, OCHOA E, LÓPEZ-ISAC E, et al; Scleroderma Genetic Consortium. A cross-disease meta-GWAS identifies four new susceptibility loci shared between systemic sclerosis and Crohn's disease. Sci Rep. 2020 Feb 5;10(1):1862. doi: 10.1038/s41598-020-58741-w.
LÓPEZ-ISAC E, ACOSTA-HERRERA M, KERICK M, et al; AUSTRALIAN SCLERODERMA INTEREST GROUP (ASIG). GWAS for systemic sclerosis identifies multiple risk loci and highlights fibrotic and vasculopathy pathways. Nat Commun. 2019 Oct 31;10(1):4955. doi: 10.1038/s41467-019-12760-y
LÓPEZ-ISAC E, MARTÍN JE, ASSASSI S, et al. Brief Report: IRF4 Newly Identified as a Common Susceptibility Locus for Systemic Sclerosis and Rheumatoid Arthritis in a Cross-Disease Meta-Analysis of Genome-Wide Association Studies. Arthritis Rheumatol. 2016 Sep;68(9):2338-44. doi: 10.1002/art.39730
MÁRQUEZ A, FERNÁNDEZ-ARANGUREN T, WITTE T, et al; Spanish GCA Group; Spanish Scleroderma Group. LILRA3 deficiency is not involved in the giant cell arteritis and systemic sclerosis predisposition. Clin Exp Rheumatol. 2016 Sep-Oct;34 Suppl 100(5):208-209
DÍEZ P, LORENZO S, DÉGANO RM, et al. Multipronged functional proteomics approaches for global identification of altered cell signalling pathways in B-cell chronic lymphocytic leukaemia. Proteomics. 2016 Apr;16(8):1193-203. doi: 10.1002/pmic.201500372.
SÁNCHEZ-JUAN P, MORENO S, DE ROJAS I, et al. The MAPT H1 Haplotype Is a Risk Factor for Alzheimer's Disease in APOE ε4 Non-carriers. Front Aging Neurosci. 2019 Dec 4;11:327. doi: 10.3389/fnagi.2019.00327. eCollection 2019.
FERNÁNDEZ-ARAUJO A, ALFONSO A, VIEYTES MR, BOTANA LM. Yessotoxin activates cell death pathways independent of Protein Kinase C in K-562 human leukemic cell line. Toxicol In Vitro. 2015 Oct;29(7):1545-54. doi: 10.1016/j.tiv.2015.05.013. Epub 2015 May 27
DAIMI H, KHELIL AH, NEJI A, BEN HAMDA K, MAAOUI S, ARANEGA A, BE CHIBANI J, FRANCO D Role of SCN5A coding and non-coding sequences in Brugada syndrome onset: What's behind the scenes?. Biomed J. 2019 Aug;42(4):252-260. doi: 10.1016/
MORENO-GRAU S, DE ROJAS I, HERNÁNDEZ I, et al. Genome-wide association analysis of dementia and its clinical endophenotypes reveal novel loci associated with Alzheimer's disease and three causality networks: The GR@ACE project. Alzheimers Dement. 2019 Oct;15(10):1333-1347. doi: 10.1016/j.jalz.2019.06.4950.
VELÁZQUEZ C, ESTEBAN-CARDEÑOSA EM, LASTRA E, et al. Unraveling the molecular effect of a rare missense mutation in BRIP1 associated with inherited breast cancer. Mol Carcinog. 2019 Jan;58(1):156-160. doi: 10.1002/mc.22910
PALENCIA-MADRID L, SÁNCHEZ-VALLE R, FERNÁNDEZ DE RETANA I, et al. A unique common ancestor introduced P301L mutation in MAPT gene in frontotemporal dementia patients from Barcelona (Baix Llobregat, Spain). Neurobiol Aging. 2019 Aug 21. pii: S0197-4580(19)30293-3. doi: 10.1016/j.neurobiolaging.2019.08.015
ORDOÑANA JR, CARRILLO E, COLODRO-CONDE L, et al. An Update of Twin Research in Spain: The Murcia Twin Registry. Twin Res Hum Genet. 2019 Sep 10:1-5. doi: 10.1017/thg.2019.60.
VALLEJO F, YUSTE JE, TERUEL-MONTOYA R, et al. First exploratory study on the metabolome from plasma exosomes in patients with paroxysmal nocturnal hemoglobinuria. Thromb Res. 2019 Oct 28;183:80-85. doi: 10.1016/j.thromres.2019.10.001
BARRIO PA, MARTÍN P, ALONSO A, et al; DNASEQEX Consortium. Massively parallel sequence data of 31 autosomal STR loci from 496 Spanish individuals revealed concordance with CE-STR technology and enhanced discrimination power. Forensic Sci Int Genet. 2019 Sep;42:49-55. doi: 10.1016/j.fsigen.2019.06.009. Epub 2019 Jun 14
ATERIDO A, PALAU N, DOMÈNECH E,et al. Genetic association between CD96 locus and immunogenicity to anti-TNF therapy in Crohn's disease. Pharmacogenomics J. 2019 May 2. doi: 10.1038/s41397-019-0090-4.
MUÑOZ-GONZÁLEZ JI, ÁLVAREZ-TWOSE I, JARA-ACEVEDO M, et al. Frequency and prognostic impact of KIT and other genetic variants in indolent systemic mastocytosis. Blood. 2019 Aug 1;134(5):456-468. doi: 10.1182/blood.2018886507.
NICOLETTI P, BARRETT S, MCEVOY L, et al. Shared Genetic Risk Factors Across Carbamazepine-Induced Hypersensitivity Reactions. Clin Pharmacol Ther. 2019 May 7. doi: 10.1002/cpt.1493
FERNÁNDEZ-SANTIAGO R, MARTÍN-FLORES N, ANTONELLI F, et al; International Parkinson's Disease Genomics Consortium, Martí MJ, Ezquerra M, Malagelada C. SNCA and mTOR Pathway Single Nucleotide Polymorphisms Interact to Modulate the Age at Onset of Parkinson's Disease. Mov Disord. 2019 Jun 24. doi: 10.1002/mds.27770.
« volver
Universidad de Salamanca
Red de biobancos
Instituto Carlos III
Junta de Castilla y León
Union Europea
Banco Nacional de ADN
Edificio Multiusos I+D+i (Universidad de Salamanca)
C/ Espejo s/n. 37007 Salamanca
Teléfono de contacto: 923294500. Ext. 5473